262 related articles for article (PubMed ID: 16825897)
1. Early diagnosis of early gastric cancer.
Tan YK; Fielding JW
Eur J Gastroenterol Hepatol; 2006 Aug; 18(8):821-9. PubMed ID: 16825897
[TBL] [Abstract][Full Text] [Related]
2. Screening of gastric cancer: who, when, and how.
Lin JT
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):135-8. PubMed ID: 24107396
[TBL] [Abstract][Full Text] [Related]
3. Evolution of the Correa's cascade steps: A long-term endoscopic surveillance among non-ulcer dyspepsia and gastric ulcer after H. pylori eradication.
Cheng HC; Yang YJ; Yang HB; Tsai YC; Chang WL; Wu CT; Kuo HY; Yu YT; Yang EH; Cheng WC; Chen WY; Sheu BS
J Formos Med Assoc; 2023 May; 122(5):400-410. PubMed ID: 36463082
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies.
de Vries AC; Kuipers EJ
Helicobacter; 2007 Nov; 12 Suppl 2():22-31. PubMed ID: 17991173
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic surveillance of gastric cancers after Helicobacter pylori eradication.
Kobayashi M; Sato Y; Terai S
World J Gastroenterol; 2015 Oct; 21(37):10553-62. PubMed ID: 26457015
[TBL] [Abstract][Full Text] [Related]
7. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice.
Quach DT; Hiyama T; Gotoda T
World J Gastroenterol; 2019 Jul; 25(27):3546-3562. PubMed ID: 31367156
[TBL] [Abstract][Full Text] [Related]
8. Berberine for gastric cancer prevention and treatment: Multi-step actions on the Correa's cascade underlie its therapeutic effects.
Liu Q; Tang J; Chen S; Hu S; Shen C; Xiang J; Chen N; Wang J; Ma X; Zhang Y; Zeng J
Pharmacol Res; 2022 Oct; 184():106440. PubMed ID: 36108874
[TBL] [Abstract][Full Text] [Related]
9. Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies.
Areia M; Carvalho R; Cadime AT; Rocha Gonçalves F; Dinis-Ribeiro M
Helicobacter; 2013 Oct; 18(5):325-37. PubMed ID: 23566268
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry.
Kuligowski J; Sanjuan-Herráez D; Vázquez-Sánchez MA; Brunet-Vega A; Pericay C; Ramírez-Lázaro MJ; Lario S; Gombau L; Junquera F; Calvet X; Quintás G
J Proteome Res; 2016 Aug; 15(8):2729-38. PubMed ID: 27384260
[TBL] [Abstract][Full Text] [Related]
11. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
12. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study.
Dore MP; Cipolli A; Ruggiu MW; Manca A; Bassotti G; Pes GM
Medicine (Baltimore); 2018 Jan; 97(4):e9734. PubMed ID: 29369216
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer.
Zhang C; Yamada N; Wu YL; Wen M; Matsuhisa T; Matsukura N
World J Gastroenterol; 2005 Feb; 11(6):791-6. PubMed ID: 15682469
[TBL] [Abstract][Full Text] [Related]
15. Personalized risk assessment for dynamic transition of gastric neoplasms.
Fann JC; Chiang TH; Yen AM; Lee YC; Wu MS; Chen HH
J Biomed Sci; 2018 Nov; 25(1):84. PubMed ID: 30453970
[TBL] [Abstract][Full Text] [Related]
16. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
17. The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia.
Cheng HC; Tsai YC; Yang HB; Yeh YC; Chang WL; Kuo HY; Lu CC; Sheu BS
Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28326664
[TBL] [Abstract][Full Text] [Related]
18. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
19. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer.
Ohata H; Kitauchi S; Yoshimura N; Mugitani K; Iwane M; Nakamura H; Yoshikawa A; Yanaoka K; Arii K; Tamai H; Shimizu Y; Takeshita T; Mohara O; Ichinose M
Int J Cancer; 2004 Mar; 109(1):138-43. PubMed ID: 14735480
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of patients with gastric precancerous conditions.
Lage J; Uedo N; Dinis-Ribeiro M; Yao K
Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):913-922. PubMed ID: 27938786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
